Meudon, France

Poul Sörensen


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Poul Sörensen: Innovator in Immune Disease Treatment

Introduction

Poul Sörensen is a notable inventor based in Meudon, France. He has made significant contributions to the field of immunology, particularly in the treatment of autoimmune and allergic diseases. With a total of 2 patents, Sörensen's work focuses on innovative therapeutic approaches that aim to improve patient outcomes.

Latest Patents

Sörensen's latest patents include a groundbreaking invention related to the treatment of immune diseases through the administration of antigen-specific formulations. This invention involves oromucosal administration of a formulation that consists of an optimized combination of antigen, tolerizing agent, and mucoadhesive carrier tailored for each immune disease indication. This innovative approach has the potential to revolutionize how autoimmune and allergic diseases are treated.

Career Highlights

Throughout his career, Poul Sörensen has been associated with Allero Therapeutics B.V., where he has been instrumental in advancing research and development in immunotherapy. His expertise and dedication to improving therapeutic strategies have positioned him as a key figure in the field.

Collaborations

Sörensen has collaborated with esteemed colleagues, including Emil Richard George Pot and Cornelis Johannes Leenhouts. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in immune disease treatment.

Conclusion

Poul Sörensen's contributions to the field of immunology through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches to treating immune diseases are paving the way for new therapeutic options that could significantly benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…